UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A quick look at the safest stablecoins for newcomers, highlighting factors like reserve transparency and market liquidity.
19,229 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
In 2026, XLK’s cap-driven approach has quietly outpaced FTEC. Concentration limits are redirecting capital toward sem...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...
Canopy Growth has slipped while the market rose. This article breaks down the reasons behind the drop, what it means ...
Ethereum sits near $2,100 in May 2026 as the market weighs upgrades, staking growth and ETF demand. This story breaks...
A surprising analyst upgrade helped StubHub Holdings stock crush expectations this week. This article breaks down the...
A major fund took a $61 million stake in a leading self-storage REIT just as a blockbuster $10.5 billion deal was win...
Investors often ask whether Netflix has the widest moat in streaming. This deep dive breaks down the moat components,...
If you have only $300 to start investing, you can still build a Buffett-inspired portfolio. This guide shows five dur...
Nvidia still dominates AI hardware, but the stock's sparkle has cooled. This article breaks down the three big reason...
Looking to build retirement wealth with a focus on AI? This guide highlights three AI stocks worth holding until reti...
As Heico reports Q2 2026 results, investors want to know if margins hold and growth remains intact. This article brea...